Garry Neil

Overview

Garry Neil received an average of $1M in total compensation, including $446K in salary, at Avalo Therapeutics between 2021 and 2022.

Source: SEC filing on October 19, 2023.

Related executives

We found 16 more executives who work or worked at Avalo Therapeutics.

Stephen Smolinski

Avalo Therapeutics

Former Chief Commercial Officer

Michael Cola

Avalo Therapeutics

Chief Executive Officer

Christopher Sullivan

Avalo Therapeutics

Chief Financial Officer

Schond Greenway

Avalo Therapeutics

Chief Financial Officer

H Wilkins

Avalo Therapeutics

Chief Medical Officer

Simon Pedder

Avalo Therapeutics

Chairman

Pericles Calias

Avalo Therapeutics

Chief Scientific Officer

Joseph Miller

Avalo Therapeutics

Chief Financial Officer

News

You may also like